| Financial Year |
March 31 2023 |
| Monetary Funds |
231,762,739.18 |
| Held-for-trading Financial Assets |
481,987,176.79 |
| Notes Receivable |
8,407,515.00 |
| Accounts Receivable |
754,210,758.33 |
| Advances to Suppliers |
53,595,948.54 |
| Other Receivables |
21,421,865.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
54,239,749.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
57,998,150.69 |
| Total Current Assets |
1,859,750,998.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
30,839,889.32 |
| Long-term Equity Investment |
60,387,841.75 |
| Investment Properties |
9,474,406.00 |
| Fixed Assetes |
92,892,151.90 |
| Under-construction Projects |
65,052,360.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
768,996,678.87 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
27,435,478.85 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,055,078,807.54 |
| Total Assets |
2,914,829,806.10 |
| Short-Term Loans |
61,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,318,193.19 |
| Accounts Payable |
513,364,564.95 |
| Accounts Received In Advance |
156,359.23 |
| Employee Compensation Payable |
1,224,193.91 |
| Taxes Payable |
16,625,840.82 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,359,772.96 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,827,560.00 |
| Other Current Liabilities |
3,498,057.76 |
| Sub-Total of Current Liabilities |
791,772,725.56 |
| Long-term Loans |
191,103,760.42 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
230,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,056,082.11 |
| Deferred Income Tax Liabilities |
5,493,324.91 |
| Other Non-Current Liabilities |
19,731,444.34 |
| Sub-Total of Non-Current Liabilities |
263,840,039.72 |
| Total Liabilities |
1,055,612,765.28 |
| Paid-In Capital(Or Share Stock) |
676,710,000.00 |
| Capital Surplus |
44,337,379.25 |
| Surplus Reserve |
108,271,509.72 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
978,096,322.38 |
| Minority Stockholder's Interest |
51,801,829.47 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,807,415,211.35 |
| Owner's Equity（Stockholder's Equity） |
1,859,217,040.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,914,829,806.10 |
